Results 11 to 20 of about 209,923 (292)

Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19–9 in periampullary cancer patients receiving pancreaticoduodenectomy

open access: yesAsian Journal of Surgery, 2021
Background: We assessed the use of serum concentrations of carbohydrate antigen (CA) 19–9 and carcinoembryonic antigen (CEA) measured during the preoperative diagnostic workup as prognostic factors for survival in patients with periampullary carcinoma ...
Sang Hun Park   +3 more
doaj   +2 more sources

Decreased serum carbohydrate antigen 19–9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients

open access: yesBMC Cancer, 2019
Background Carbohydrate antigen (CA) 19–9 levels after resection are considered to predict prognosis; however, the significance of decreased CA19–9 levels after neoadjuvant therapy has not been clarified.
Shuichi Aoki   +16 more
doaj   +2 more sources

Peritoneal Tuberculosis Mimicking Cancerous Peritonitis With Elevated Serum Cancer Antigen 125 and Carbohydrate Antigen 19‐9 Levels: A Case Report [PDF]

open access: yesRespirology Case Reports
Peritoneal tuberculosis (PTB) is a rare extrapulmonary manifestation that poses diagnostic challenges due to nonspecific clinical features and can mimic carcinomatous peritonitis, particularly in patients with ascites and elevated serum cancer antigen ...
Toshiki Morimoto   +10 more
doaj   +2 more sources

High carbohydrate antigen 19–9 levels indicate poor prognosis in patients with bladder cancer following radical cystectomy [PDF]

open access: yesFrontiers in Oncology
IntroductionOur team previously reported that elevated carbohydrate antigen (CA) 19–9 levels are associated with a worse prognosis in upper tract urothelial carcinoma (UTUC).
Sang Won So   +13 more
doaj   +2 more sources

Holistic Understanding of the Role of Carbohydrate Antigen 19-9 in Pancreatic Cancer Screening, Early Diagnosis, and Prognosis: A Systematic Review. [PDF]

open access: yesCureus, 2023
Pancreatic ductal adenocarcinoma (PDAC) is a significant challenge due to its silent progression and well-advanced, unresectable, complicated presentation.
Janga LSN   +6 more
europepmc   +2 more sources

Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer. [PDF]

open access: yesWorld J Clin Oncol, 2022
BACKGROUND Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of death from cancer worldwide. Tumor markers like carbohydrate antigen 19-9 (CA 19-9) have been proven valuable as a diagnostic tool and a predictor for tumor staging and response to ...
Balaban DV   +11 more
europepmc   +2 more sources

Tumor-Associated Carbohydrate Antigen 19-9 (CA 19-9), a Promising Target for Antibody-Based Detection, Diagnosis, and Immunotherapy of Cancer. [PDF]

open access: yesChemMedChem
Carbohydrate antigen 19–9 (CA 19–9) also known as sialyl Lewis A is a tetrasaccharide overexpressed on a wide range of cancerous cells. CA 19–9 has been detected at elevated levels in sera of patients with various types of malignancies, most prominently ...
Nakisa A   +6 more
europepmc   +2 more sources

Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Cancer Antigen 125, Prostate-Specific Antigen and Other Cancer Markers: A Primer on Commonly Used Cancer Markers

open access: yesWorld Journal of Oncology, 2023
Cancer markers are molecules produced by cancer cells which may serve to identify the presence of cancer. Cancer markers can be differentiated as serum-based, radiology-based and tissue-based, and are one of the most important tools in diagnosing ...
Shreya Desai, A. Guddati
semanticscholar   +1 more source

Carbohydrate antigen 19-9 — tumor marker: Past, present, and future

open access: yesWorld Journal of Gastrointestinal Surgery, 2020
Carbohydrate antigen 19-9 (CA 19-9) is a cell surface glycoprotein complex most commonly associated with pancreatic ductal adenocarcinoma (PDAC). Koprowski first described it in 1979 using a mouse monoclonal antibody in a colorectal carcinoma cell line ...
Tsinrong Lee, T. Teng, V. Shelat
semanticscholar   +1 more source

Novel tumor marker index using carcinoembryonic antigen and carbohydrate antigen 19-9 is a significant prognostic factor for resectable colorectal cancer. [PDF]

open access: yesSci Rep
We evaluated the usefulness of a newly devised tumor marker index (TMI), namely, the geometric mean of normalized carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9), in determining colorectal cancer (CRC) prognosis.
Kamada T   +9 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy